Autosomal dominant tibial muscular dystrophy in Estonia
Siiri Sarv(Tartu University Hospital), Katrin Õunap(Tartu University Hospital), Tiina Kahre, Laura Mihkla(Tartu University Hospital), Peter Hackman(Folkhälsans Forskningscentrum), Ülle Murumets, Eve Õiglane‐Shlik(Tartu University Hospital), Katrin Gross‐Paju, Tiia Reimand(Tartu University Hospital), Sanna Puusepp(Tartu University Hospital), Marco Savarese(Folkhälsans Forskningscentrum), Bjarne Udd(Folkhälsans Forskningscentrum), Liis Väli, Lisanna Põlluaas, T. Turku, Sandra Ütt, Sander Pajusalu(MACOM (United States))
Cited by 1
Related Papers
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
|The American Journal of Human Genetics|2017|456
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420